Page last updated: 2024-11-04

sulfasalazine and Diffuse Mixed Small and Large Cell Lymphoma

sulfasalazine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
" Events included eight patients with malignancies, two with pancytopenia taking methotrexate, three with septic arthritis, and two with septicaemias."3.71Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience. ( Bevan, J; Homer, D; Jobanputra, P; Maggs, F, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jobanputra, P1
Maggs, F1
Homer, D1
Bevan, J1

Other Studies

1 other study available for sulfasalazine and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience.
    Drug safety, 2002, Volume: 25, Issue:15

    Topics: Antirheumatic Agents; Arthritis, Infectious; Azathioprine; Drug Monitoring; Humans; Hypokalemia; Lun

2002